As of 2026-09-28, the Intrinsic Value of Design Therapeutics Inc (DSGN) is -5.67 USD. This DSGN valuation is based on the model Peter Lynch Fair Value. With the current market price of 12.12 USD, the upside of Design Therapeutics Inc is -146.76%.
Based on its market price of 12.12 USD and our intrinsic valuation, Design Therapeutics Inc (DSGN) is overvalued by 146.76%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.67 - -5.67 | -5.67 | -146.76% |
| P/E | (29.02) - (29.13) | (29.87) | -346.4% |
| DDM - Stable | (17.92) - (184.80) | (101.36) | -936.3% |
| DDM - Multi | (2.15) - (17.07) | (3.80) | -131.4% |
| Market Cap (mil) | 757.02 |
| Beta | 0.71 |
| Outstanding shares (mil) | 62.46 |
| Enterprise Value (mil) | 744.11 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.49% |
| Cost of Debt | 5.00% |
| WACC | 5.19% |